Get latest articles and stories on Science at LatestLY. A new class of glioma medications takes advantage of tumours lacking the DNA repair enzyme MGMT; the medications cause the generation of cytotoxic DNA and kill tumour cells specifically without the risk of developing resistance, according to research. Science News | Research Reveals Glioma Drug Exploits DNA Repair Defects to Selectively Target Drug-resistant Tumors.